The Rs 5,800 crore valuation will be an EBITDA (earnings before interest, taxes, depreciation, and amortisation) multiple of about 24 times since in FY19 Medanta had posted EBITDA of Rs 240 crore, up 8% year-on-year.
Medanta's promoters - Trehan, his family members, and cofounder Sunil Sachdeva, who jointly own 55 per cent of the company - will reportedly sell their entire stake to Ranjan Pai-owned Manipal. The deal will also give an exit to the Gurgaon-based hospital chain's current investors such as Carlyle and Temasek, who have agreed on the price already.
In December 2013, US-based investment entity Carlyle Group had bought a 27 per cent stake in Medanta from PE firm Avenue Capital for Rs 960 crore, valuing the company at around Rs 3,550 crore. Two years later, an arm of Singapore's state-owned investment company Temasek acquired Punj Lloyd's entire 17.74 per cent stake in Global Health Pvt Ltd, which owns Medanta Medicity hospital.
"Though most of the financing will be done by Ranjan Pai through equity and internal accruals, [Manipal's] existing investors TPG and Temasek will also participate in this acquisition," the source added. Pai owns 60% of Manipal Hospitals through the promoter holding company, while TPG holds a 22% stake and Temasek owns the rest.
The daily previously reported that the world's largest private equity firm Blackstone had held discussions with Pai with a Rs 3,200 crore ($450 million) funding commitment for the Medanta buyout.
This deal will give Manipal a much-needed presence in North India. Medanta, founded in 2009, operates super speciality hospitals and clinics in cities such as Gurgaon, Lucknow, Indore, Ranchi and Sri Ganganagar.
Experts say that demonetisation, GST, tightening of cash transactions and the price caps imposed by the drug pricing regulator have impacted some of the smaller establishments making them unviable, paving the way for more mergers and acquisitions going ahead.
Manipal Hospital Chairman H. Sudarshan Ballal told PTI in December that the "future healthcare will be a high-volume, low-margin venture", inching towards universal health care with an active role played by the government. So 2019 may well see the closure of some individual-driven smaller facilities. Meanwhile, the biggies in the business and PE firms are closely watching the healthcare space.
With PTI inputs
Also read: Max India gets shareholders' nod for stake sale in health insurance biz
Also read: Delay in open offer: IHH says it 'understands concerns' of Fortis' minority shareholders